Biologics and Small Molecule Inhibitors: an Update in Therapies for Allergic and Immunologic Skin Diseases

PURPOSE OF REVIEW: Biologics and small molecule inhibitors (SMIs) are a rapidly growing class of highly efficacious therapies in the treatment of chronic immunologic and allergic conditions. With precision targeting of inflammatory signaling molecules, these new agents selectively modulate the immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Dodson, Joseph, Lio, Peter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Allergic Skin Diseases (L Fonacier, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643971/
https://www.ncbi.nlm.nih.gov/pubmed/36348149
http://dx.doi.org/10.1007/s11882-022-01047-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643971/
https://www.ncbi.nlm.nih.gov/pubmed/36348149
http://dx.doi.org/10.1007/s11882-022-01047-w

Ejemplares similares